Sarepta therapeutics announces fifth year of route 79, the duchenne scholarship program

Cambridge, mass., march 08, 2022 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today announced that the website for route 79, the duchenne scholarship program, is officially open and accepting applications. academic scholarships of up to $5,000 will be awarded to up to 15 individuals living with duchenne. additionally, for the 2022-2023 school year, the program has been expanded and sarepta will be awarding up to 5 academic scholarships of $5,000 to siblings of individuals living with duchenne.
SRPT Ratings Summary
SRPT Quant Ranking